Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Mar;17(2):358-69.
doi: 10.1208/s12248-014-9697-1. Epub 2014 Dec 12.

Enhancement of MHC-I antigen presentation via architectural control of pH-responsive, endosomolytic polymer nanoparticles

Affiliations

Enhancement of MHC-I antigen presentation via architectural control of pH-responsive, endosomolytic polymer nanoparticles

John T Wilson et al. AAPS J. 2015 Mar.

Abstract

Protein-based vaccines offer a number of important advantages over organism-based vaccines but generally elicit poor CD8(+) T cell responses. We have previously demonstrated that pH-responsive, endosomolytic polymers can enhance protein antigen delivery to major histocompatibility complex class I (MHC-I) antigen presentation pathways thereby augmenting CD8(+) T cell responses following immunization. Here, we describe a new family of nanocarriers for protein antigen delivery assembled using architecturally distinct pH-responsive polymers. Reversible addition-fragmentation chain transfer (RAFT) polymerization was used to synthesize linear, hyperbranched, and core-crosslinked copolymers of 2-(N,N-diethylamino)ethyl methacrylate (DEAEMA) and butyl methacrylate (BMA) that were subsequently chain extended with a hydrophilic N,N-dimethylacrylamide (DMA) segment copolymerized with thiol-reactive pyridyl disulfide (PDS) groups. In aqueous solution, polymer chains assembled into 25 nm micellar nanoparticles and enabled efficient and reducible conjugation of a thiolated protein antigen, ovalbumin. Polymers demonstrated pH-dependent membrane-destabilizing activity in an erythrocyte lysis assay, with the hyperbranched and cross-linked polymer architectures exhibiting significantly higher hemolysis at pH ≤ 7.0 than the linear diblock. Antigen delivery with the hyperbranched and cross-linked polymer architecture enhanced in vitro MHC-I antigen presentation relative to free antigen, whereas the linear construct did not have a discernible effect. The hyperbranched system elicited a four- to fivefold increase in MHC-I presentation relative to the cross-linked architecture, demonstrating the superior capacity of the hyperbranched architecture in enhancing MHC-I presentation. This work demonstrates that the architecture of pH-responsive, endosomolytic polymers can have dramatic effects on intracellular antigen delivery, and offers a promising strategy for enhancing CD8(+) T cell responses to protein-based vaccines.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
pH-responsive nanoparticles assembled using polymer chains of different architectures were utilized as carriers for delivery of protein antigen into the MHC-I antigen processing pathway. a pH-responsive diblock copolymers were synthesized with linear, core-crosslinked, or hyperbranched architectures. The pH-responsive, endosomolytic component (red) is a copolymer of butyl methacrylate (BMA) and 2-(N,N-diethylamino)ethyl methacrylate (DEAEMA) which was chain extended with a copolymer of dimethylacrylamide (DMA) doped with a pyridyl disulfide functionalized monomer (PDSMA) for antigen conjugation. b Polymer chains of all architectures assembled into nanoparticles under aqueous conditions at neutral pH, PDS groups were used for conjugation of protein antigen via disulfide exchange. c Nanocarriers composed of architecturally distinct polymer chains were evaluated for their ability to enhance MHC-I antigen presentation by dendritic cells
Scheme 1
Scheme 1
Synthesis of [BMA-co-DEAEMA]-b-[DMA-co-PDSMA] polymers of linear (a), hyperbranched (b), or core-crosslinked (c) architecture. Block extension of these architectures by DMA and PDSMA (d)
Fig. 2
Fig. 2
Evolution plot of polydispersity (Ð) and molar mass progression (M n (GPC)) with DEAEMA conversion vs. calculated molar mass (M n (calc)) for DEAEMA-co-BMA polymers (top) of linear (a), cross-linked (b), and hyperbranched (c) architecture. Representative molar mass distributions (bottom) of DEAEMA-co-BMA mCTA (dotted line) and [DEAEMA-co-BMA]-b-[DMA-co-PDSMA] diblock copolymer (solid line) of linear (a), hyperbranched (b), and cross-linked (c) architectures
Fig. 3
Fig. 3
Dynamic light scattering (DLS) characterization of pH-responsive diblock copolymers (high pH-responsive polymer content; see Table I) in aqueous solution. a Representative size distribution (number average diameter) of particles at pH 7.4 in HEPES-buffered glucose. b Particle size measurements of copolymers as a function of pH (0.5 mg/mL in 10 mM sodium phosphate buffer with 150 mM NaCl)
Fig. 4
Fig. 4
Erythrocyte lysis assay demonstrating pH-dependent membrane-destabilizing activity of copolymers with linear, cross-linked, and hyperbranched architectures. a Total polymer concentration fixed at 1.25 μg/mL. b Polymer concentration normalized to 1.25 μg/mL of the pH-responsive element (DEAEMA-co-BMA). c Hemolytic activity of polymers with higher mass fraction of hydrophilic DMA-co-PDSMA block (lower pH-responsive content), normalized to 1.25 μg/mL of the pH-responsive element. Data represent mean ± SD, n = 4
Fig. 5
Fig. 5
Antigen conjugation to pH-responsive polymer nanoparticles via disulfide exchange reaction. a Size of nanoparticles (number average diameter) by dynamic light scattering after reaction with thiolated ovalbumin (ova-SH) at 0, 0.35, 0.175, and 0.0875 mg ova/mg polymer. b SDS-PAGE of fluorescently labeled ovalbumin (ova) and ova-nanoparticle conjugates (0.35 mg ova/mg polymer) prepared using linear (L), hyperbranched (HB), or cross-linked (CL) polymers. Incubation of conjugates with TCEP liberates ova from the carrier. c SDS-PAGE of fluorescently labeled ova and ova-nanoparticle conjugates (c) and a physical mixture (m) of polymers and non-thiolated ova
Fig. 6
Fig. 6
a Effect of polymer architecture on MHC class I presentation in an in vitro co-culture model. Murine dendritic cells (DC2.4) were incubated with free antigen (ova) or conjugates prepared using polymers of different architecture and subsequently co-cultured with B3Z T cells which produce β-galactosidase in response to antigen presentation on MHC-I. Data are from a single representative experiment conducted in quadruplicate (mean ± standard deviation). b Uptake of Alexa Fluor 488-labeled ova measured by DC2.4 cells after 5 h at 37°C as measured by flow cytometry (MFI median fluorescent intensity). Data are from a single experiment conducted in triplicate (mean ± standard deviation)

References

    1. Foged C, Hansen J, Agger EM. License to kill: formulation requirements for optimal priming of CD8(+) CTL responses with particulate vaccine delivery systems. Eur J Pharm Sci. 2012;45(4):482–491. doi: 10.1016/j.ejps.2011.08.016. - DOI - PubMed
    1. Yewdell JW. Designing CD8+ T cell vaccines: it’s not rocket science (yet). Current opinion in immunology. Elsevier Ltd; 2010 Jun 1;22(3):402–10. - PMC - PubMed
    1. Reed SG, Orr MT, Fox CB. Key roles of adjuvants in modern vaccines. Nat Med. 2013;19(12):1597–1608. doi: 10.1038/nm.3409. - DOI - PubMed
    1. Flatz L, Hegazy AN, Bergthaler A, Verschoor A, Claus C, Fernandez M, et al. Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity. Nat Med. 2010;16(3):339–345. doi: 10.1038/nm.2104. - DOI - PMC - PubMed
    1. Rollier CS, Reyes-Sandoval A, Cottingham MG, Ewer K, Hill AV. Viral vectors as vaccine platforms: deployment in sight. Curr Opin Immunol. 2011;23(3):377–382. doi: 10.1016/j.coi.2011.03.006. - DOI - PubMed

Publication types